Arcosa (ACA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
3 Aug, 2026Executive summary
A special meeting is scheduled for September 4, 2026, to vote on a merger agreement with CRH Americas, Inc., under which shareholders will receive $150.00 per share in cash if the merger is approved and completed.
The board unanimously recommends voting in favor of the merger, the related executive compensation proposal, and the adjournment proposal if needed.
The merger is expected to close in the first quarter of 2027, subject to regulatory and shareholder approvals and other customary closing conditions.
Voting matters and shareholder proposals
Shareholders will vote on: (1) approval of the merger agreement, (2) a non-binding advisory vote on executive compensation related to the merger, and (3) adjournment of the meeting if necessary.
Approval of the merger requires a majority of outstanding shares; abstentions and broker non-votes count as votes against.
Shareholders who do not vote in favor may seek appraisal rights under Delaware law.
Board of directors and corporate governance
The board, after consulting with legal and financial advisors, determined the merger is fair and in the best interests of shareholders.
The board considered strategic alternatives and concluded the all-cash offer at a premium was the best available option.
The board's recommendation is based on a comprehensive review of financial, strategic, and market factors.
Latest events from Arcosa
- Stockholders to vote on $150/share all-cash acquisition by CRH, pending Q1 2027 close.ACA
Proxy filing - Revenue and profit rose, with strategic divestiture and a pending merger defining the quarter.ACA
Q2 2026 - Shareholders to vote on a $150/share all-cash merger, with board unanimous support and appraisal rights.ACA
Proxy filing - Stavola acquisition accelerates infrastructure focus, margin growth, and long-term value creation.ACA
Sidoti September Small-Cap Virtual Conference - CRH’s $8.5B acquisition of Arcosa offers a 25% premium and accelerates infrastructure growth.ACA
Proxy filing - Arcosa to be acquired by CRH for $8.5B, with shareholders receiving $150 per share.ACA
Proxy filing - Definitive agreement for acquisition by CRH announced, pending shareholder approval in Q1 2027.ACA
Proxy filing - Agreement reached for $8.5B acquisition by CRH, pending shareholder approval.ACA
Proxy filing - Adjusted EBITDA up 26% and margin expands, with 2025 guidance reaffirmed amid resilient markets.ACA
Q1 2025